المؤلفون: Fernández-Navarro P; Cancer and Environmental Epidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health, Madrid, 28029, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, 28029, Spain., López-Nieva P; Department of Cellular Biology and Immunology, Severo Ochoa Molecular Biology Center (CBMSO), CSIC-Madrid Autonomous University, Madrid, 28049, Spain.; Institute of Health Research Jiménez Díaz Foundation, Madrid, 28040, Spain.; Consortium for Biomedical Research in Rare Diseases (CIBERER), Carlos III Institute of Health, Madrid, 28029, Spain., Piñeiro-Yañez E; Bioinformatics Unit, Structural Biology and Biocomputing Programme, Spanish National Cancer Research Center (CNIO), Madrid, 28029, Spain., Carreño-Tarragona G; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, 28041, Spain., Martinez-López J; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, 28041, Spain., Sánchez Pérez R; Department of Congenital Cardiac Surgery, Hospital Universitario La Paz, Madrid, 28046, Spain., Aroca Á; Department of Congenital Cardiac Surgery, Hospital Universitario La Paz, Madrid, 28046, Spain., Al-Shahrour F; Bioinformatics Unit, Structural Biology and Biocomputing Programme, Spanish National Cancer Research Center (CNIO), Madrid, 28029, Spain., Cobos-Fernández MÁ; Department of Cellular Biology and Immunology, Severo Ochoa Molecular Biology Center (CBMSO), CSIC-Madrid Autonomous University, Madrid, 28049, Spain.; Institute of Health Research Jiménez Díaz Foundation, Madrid, 28040, Spain., Fernández-Piqueras J; Department of Cellular Biology and Immunology, Severo Ochoa Molecular Biology Center (CBMSO), CSIC-Madrid Autonomous University, Madrid, 28049, Spain. jfpiqueras@cbm.csic.es.; Institute of Health Research Jiménez Díaz Foundation, Madrid, 28040, Spain. jfpiqueras@cbm.csic.es.; Consortium for Biomedical Research in Rare Diseases (CIBERER), Carlos III Institute of Health, Madrid, 28029, Spain. jfpiqueras@cbm.csic.es.

المصدر: BMC cancer [BMC Cancer] 2019 Oct 26; Vol. 19 (1), pp. 1005. Date of Electronic Publication: 2019 Oct 26.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Genome, Human/*genetics , Genomics/*methods , Precision Medicine/*methods , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/*drug therapy, Adolescent ; Alternative Splicing/genetics ; Exome/genetics ; Gene Fusion/genetics ; High-Throughput Nucleotide Sequencing ; Humans ; Male ; Mutation/genetics ; RNA-Seq ; Spain ; Transcriptome/genetics

عنوان ترانسليتريتد: Leucemia linfoblástica aguda T pediátrica: análisis de supervivencia y factores pronósticos en 4 protocolos consecutivos del grupo cooperativo multicéntrico SHOP.

المؤلفون: Rives S; Hematología Pediátrica, Hospital Sant Joan de Déu, Universitat de Barcelona, España. srives@hsjdbcn.org, Estella J, Camós M, García-Miguel P, Verdeguer A, Couselo JM, Tasso M, Molina J, Gómez P, Fernández-Delgado R, Navajas A, Badell I

مؤلفون مشاركون: grupo cooperativo SHOP (Sociedad Española de Hemato-Oncología Pediátrica)

المصدر: Medicina clinica [Med Clin (Barc)] 2012 Jul 07; Vol. 139 (4), pp. 141-9. Date of Electronic Publication: 2012 Mar 28.

نوع المنشور: Evaluation Study; Journal Article; Multicenter Study

بيانات الدورية: Publisher: Elsevier España Country of Publication: Spain NLM ID: 0376377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1578-8989 (Electronic) Linking ISSN: 00257753 NLM ISO Abbreviation: Med Clin (Barc) Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/*drug therapy, Adolescent ; Antineoplastic Agents/administration & dosage ; Child ; Child, Preschool ; Consolidation Chemotherapy ; Female ; Follow-Up Studies ; Humans ; Induction Chemotherapy ; Infant ; Maintenance Chemotherapy ; Male ; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/mortality ; Retrospective Studies ; Spain ; Survival Analysis ; Treatment Outcome

المؤلفون: Martínez-Laperche C; Servicio de Oncohematología, Hospital Universitario Niño Jesús, Madrid, Spain., Gómez-García AM, Lassaletta Á, Moscardó C, Vivanco JL, Molina J, Fuster JL, Couselo JM, de Toledo JS, Bureo E, Madero L, Ramírez M

المصدر: American journal of hematology [Am J Hematol] 2013 May; Vol. 88 (5), pp. 359-64. Date of Electronic Publication: 2013 Mar 07.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Meningeal Neoplasms/*diagnosis , Precursor Cell Lymphoblastic Leukemia-Lymphoma/*cerebrospinal fluid, Adolescent ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Child ; Child, Preschool ; Cohort Studies ; Early Diagnosis ; Female ; Follow-Up Studies ; Humans ; Infant ; Injections, Spinal ; Maintenance Chemotherapy ; Male ; Meningeal Neoplasms/epidemiology ; Meningeal Neoplasms/secondary ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/diagnosis ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/physiopathology ; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/cerebrospinal fluid ; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/diagnosis ; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/drug therapy ; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/physiopathology ; Prognosis ; Prospective Studies ; Recurrence ; Risk Factors ; Spain/epidemiology ; Survival Analysis